The 4 Pinch Points Facing Global Clinical Trial Comparator Sourcing

With less than two weeks to go before this “Turbo-Webinar,” the majority of registrants have selected “Ways to Avoid Continuity of Supply Issues” to be the topic discussed on the 7th March.

Naturally, the three other proposed topics will be highlighted where they touch upon Continuity of Supply.

 

Ways to Avoid Continuity of Supply Issues

(i) These are some of the implications for you when facing continuity of supply issues:

  • Unexpected delays to your planned completion date.
  • Recruited patients already receiving medication may need to drop out of your trial.
  • Newly recruited patients may lost to the trial if no initial medication is available.
  • You may incur significant unbudgeted costs to source from alternative markets.

 

(ii) These are some of the big, internal issues that you company will need to address:

  • The trial may have to be delayed or even cancelled if the comparator that you started the trial with is suddenly unavailable
  • The overall outcome of the trial will potentially be jeopardised if the trial does not use products consistent with the trial requirements
  • The market value of your organisation may be impacted if promised milestones are missed.

 

…and here are some of the solutions that can address these challenges:

  • Innovative dynamic inventory builds to ensure de-risked resupply
  • Built-in flexibility of sourcing & diversified supply options.
  • Provision of pre-planning market dynamics reviews to ensure that optimal sourcing strategy in adopted and maintained
  • Pro-active predictive market intelligence to navigate avoidable disruption to supply over the life of the trial.

 

The above and more will be discussed by Ian Hoban and Lucy Fox on the 7th March.